Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 14, 2006; 12(2): 199-203
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.199
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.199
E-cadherin in gastric cancer
Annie On On Chan, Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
Correspondence to: Annie On On Chan, MD, PhD, Honorary Clinical Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. aoochan@hku.hk
Telephone: +852-2855-5414 Fax: +852-2855-5411
Received: June 7, 2005
Revised: June 28, 2005
Accepted: July 11, 2005
Published online: January 14, 2006
Revised: June 28, 2005
Accepted: July 11, 2005
Published online: January 14, 2006
Abstract
Cadherin is an adhesion molecule and a superfamily of calcium-mediated membrane glycoproteins. E-cadherin is the prototype of the class E-cadherin that links to catenins to form the cytoskeleton. Recent evidence has shown that E-cadherin not only acts as an adhesive, but also plays important roles in growth development and carcinogenesis. It has been recently viewed as an invasion as well as a growth suppressor gene. This review summarizes the recent discoveries on E-cadherin and its role in gastric cancer. In particular, our work on E-cadherin in gastric cancer, including its relation with Helicobacter pylori and clinical applications, are described in detail.
Keywords: E-cadherin; Gastric cancer